Q3 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INSP | Exit | Inspire Medical Systems, Inc. | $0 | – | -396,406 | – | -96.96% | – |
Q2 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INSP | New | Inspire Medical Systems, Inc. | $34,495,000 | – | 396,406 | – | 96.96% | – |
| AMRS | New | Amyris, Inc. | $1,080,000 | – | 252,834 | – | 3.04% | – |
Q4 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMRS | Exit | Amyris Biotechnologies, Inc. | $0 | – | -252,834 | – | -2.34% | – |
| INSP | Exit | Inspire Medical Systems, Inc. | $0 | – | -396,406 | – | -47.02% | – |
| CBLK | Exit | Carbon Black, Inc. | $0 | – | -1,002,253 | – | -50.64% | – |
Q2 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INSP | New | Inspire Medical Systems, Inc. | $24,042,000 | – | 396,406 | – | 57.66% | – |
| CBLK | New | Carbon Black, Inc. | $16,758,000 | – | 1,002,253 | – | 40.19% | – |
| AMRS | New | Amyris Biotechnologies, Inc. | $900,000 | – | 252,834 | – | 2.16% | – |